Securities code: 688607 securities abbreviation: Careray Digital Medical Technology Co.Ltd(688607) Announcement No.: 2022-013 Careray Digital Medical Technology Co.Ltd(688607)
Announcement on share reduction plan of shareholders holding more than 5%
The board of directors, all directors and relevant shareholders of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Important content tips:
Basic information of shareholding of major shareholders
As of February 15, 2022, Changcheng Co., Ltd., matrix future Limited (hereinafter referred to as “Changcheng”) held 13089380 shares of Careray Digital Medical Technology Co.Ltd(688607) (hereinafter referred to as ” Careray Digital Medical Technology Co.Ltd(688607) ” or “the company”), accounting for 14.85% of the total share capital of the company. The total share capital of the company (hereinafter referred to as “Holly health”) is 5055.74% of that of “Holly health” Co., Ltd. (hereinafter referred to as “Holly health”). Changcheng and Junlian Chengyu are persons acting in concert. Their shares are obtained before the company’s IPO. This part of the shares will expire and be listed and circulated from February 7, 2022.
Main contents of share reduction plan
Changcheng plans to reduce its holdings of no more than 3814450 shares, Junlian Chengyu plans to reduce its holdings of no more than 1473250 shares, and the two plans to reduce their holdings of no more than 5287700 shares in total (if the company has changes in shares such as share distribution and conversion of capital reserve into share capital during the planned reduction period, the number of shares above shall be adjusted accordingly), That is, the total reduction of the two companies shall not exceed 6.00% of the total share capital of the company. Where the shares are reduced by means of centralized bidding, the total number of shares reduced by the two companies in any continuous 90 natural days shall not exceed 1% of the total number of shares of the company; If the shares are reduced by block trading, the total number of shares reduced by the two companies in any continuous 90 natural days shall not exceed 2% of the total number of shares of the company. 1、 Basic information of the reducing entity
Shareholder name shareholder identity shareholding number (shares) shareholding proportion current shareholding source
More than 5% obtained before the first largest IPO: 13089380 Changcheng 13089380 14.85%
Shareholder shares
More than 5% non first
Junlian Chengyu obtained 5.74% before IPO: 5055490 major shareholders
There are persons acting in concert with the above reduction subjects:
Name of shareholders number of shares (shares) shareholding ratio concerted action relationship formation reasons
The first group of Changcheng 13089380 14.85% of the actual situation of Changcheng and Jun lianchengyu
The controller is Junlian capital management
Li Co., Ltd
Junlian Chengyu 5055490 5.74% actual of Changcheng and Junlian Chengyu
The controller is Junlian capital management
Li Co., Ltd
Total 18144870 20.59% –
As of the disclosure date of this announcement, the aforesaid major shareholders and their persons acting in concert have not reduced their shares since the IPO.
2、 Main contents of share reduction plan
Planned reduction planned reduction competitive trading reduction reasonable proposed reduction shareholder name proposed reduction method
Quantity (share) holding proportion price range share source reason during reduction period
Changcheng no more than: no more than bidding transaction minus 2022 / 3 / 9, taking its own capital 3814,45 before IPO according to the market price, no more than: ~ gedejin needs 0 shares, 4.33% 1271490 shares, 2022 / 9 / 8
Block trading minus
Hold, not exceeding:
2542960 shares
Junlian Chengyu no more than: no more than bidding transaction minus 2022 / 3 / 9, taking its own capital 1473250 before IPO at the market price, no more than: ~ gedejin demand
1.67% 491090 shares 2022 / 9 / 8
Block trading minus
Hold, not exceeding:
982160 shares
(I) whether the relevant shareholders have other arrangements □ yes √ no
(II) whether the major shareholders and the directors, supervisors and senior management have made commitments on the shareholding ratio, shareholding quantity, shareholding period, reduction method, reduction quantity, reduction price, etc. √ yes □ no
If the unit reduces the shares of the company held by the unit directly or indirectly before the issuance and listing after the expiration of the lock-in period, the reduction procedures shall strictly comply with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, and several provisions on the reduction of shares by shareholders, directors and supervisors of listed companies Provisions on share reduction and information disclosure in laws, regulations and normative documents such as the Listing Rules of Shanghai Stock Exchange’s science and innovation board and the detailed rules for the implementation of share reduction by shareholders, directors, supervisors and senior managers of listed companies on Shanghai Stock Exchange.
After the issuance of this commitment, if there is any inconsistency between the new laws and regulations, the provisions of the CSRC and the normative documents of the Shanghai Stock Exchange and the content of this commitment, the new laws and regulations, the provisions of the CSRC and the normative documents of the Shanghai Stock Exchange shall prevail.
Whether the proposed reduction is consistent with the previously disclosed commitments √ yes □ no
(III) whether it is a non-profit company at the time of listing, and its controlling shareholders, actual controllers, directors, supervisors and senior managers plan to reduce their pre IPO shares □ yes √ no
(IV) other matters required by the exchange III. reduction of shares held by controlling shareholders or actual controllers before the initial public offering
Whether the controlling shareholder or actual controller intends to reduce the shares before the initial public offering □ yes √ no
4、 Relevant risk tips (I) uncertain risks of the implementation of the reduction plan, such as the preconditions and restrictive conditions for the implementation of the plan, as well as the specific conditions for the achievement or elimination of relevant conditions, etc
1. The implementation of the reduction plan is uncertain. Changcheng and Junlian Chengyu will decide whether to implement the reduction plan according to the market conditions and stock prices.
2. Changcheng and Junlian Chengyu are not the controlling shareholders and actual controllers of the company. The share reduction plan is the normal reduction of shareholders and will not have a significant impact on the corporate governance structure, equity structure and future sustainable operation, nor will it lead to the change of the company’s control.
3. The reduction of Changcheng and Junlian Chengyu will strictly abide by the provisions of relevant laws, regulations and normative documents, and fulfill the obligation of disclosure in time. (II) whether the implementation of the share reduction plan may lead to the risk of change in the control of the listed company □ yes √ no (III) other risk tips
nothing
It is hereby announced.
Careray Digital Medical Technology Co.Ltd(688607) board of directors February 16, 2022
